methylergonovine has been researched along with papaverine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Linka, F; Mosler, KH | 1 |
| INGELMAN-SUNDBERG, A; RYDEN, A; SANDBERG, F | 1 |
2 review(s) available for methylergonovine and papaverine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Clinical pharmacology in obstetrics: regulation of the uterus].
Topics: Adrenergic beta-Agonists; Aspirin; Ergotamine; Female; Humans; Indomethacin; Methylergonovine; Obstetric Labor Complications; Obstetric Labor, Premature; Oxytocics; Oxytocin; Papaverine; Pregnancy; Pregnancy Complications; Prostaglandins; Uterine Contraction; Uterus | 1975 |
1 other study(ies) available for methylergonovine and papaverine
| Article | Year |
|---|---|
In vitro studies of the motility of the human fallopian tube. II. The effects of methylergometrine and papaverine.
Topics: Animals; Cell Movement; Fallopian Tubes; Female; Humans; In Vitro Techniques; Methylergonovine; Papaverine | 1963 |